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cl-2 family members Bak and Bax constitute a mito-
chondrial gateway for multiple death pathways.
Both proteins are also present in the endoplasmic
reticulum where they control apoptosis through the regu-
lation of calcium levels. We show here that reticular Bak
has the additional capacity of modulating the structure
of this organelle. Coexpression of Bak and Bcl-X
 
L
 
 pro-
vokes extensive swelling and vacuolization of reticular
cisternae. A Bak version lacking the BH3 domain sufﬁces
to induce this phenotype, and reticular targeting of this
mutant retains the activity. Expression of upstream BH3-
B
 
only  activators in similar conditions recapitulates ER
swelling and vacuolization if ryanodine receptor calcium
channel activity is inhibited. Experiments with Bak and
Bax-deﬁcient mouse embryonic ﬁbroblasts show that
endogenous Bak mediates the effect, whereas Bax is
mainly irrelevant. These results reveal a previously uni-
dentiﬁed role of Bak in regulating reticular conformation.
Because this activity is absent in Bax, it constitutes one of
the ﬁrst examples of functional divergence between the
two multidomain homologues.
 
Introduction
 
Apoptotic cell death ensures the elimination of cells that become
irrelevant or potentially damaging for the organism (Danial
and Korsmeyer, 2004), and the Bcl-2 family of proteins plays a
central role in the regulation of this process (Adams and Cory,
1998). This family includes both pro- and anti-apoptotic mole-
cules sharing homology in any of the four Bcl-2 homology (BH)
domains identified so far (BH1 to 4; Adams and Cory, 1998).
The role of Bcl-2 proteins in the regulation of mitochondrial
apoptosis has been clearly established (Green and Reed, 1998).
However, functions in other subcellular compartments, like the
ER, are beginning to be discovered (Breckenridge et al., 2003).
Based on both structural and functional criteria, three
subgroups of Bcl-2 homologues have been identified. One of
them includes pro-apoptotic effectors like Bak and Bax, char-
acterized by containing three of the prototypical BH domains
(BH1, BH2, and BH3; Adams and Cory, 1998; Reed, 1998).
A functional BH3 domain has been shown to be critical for
the apoptotic activity of these proteins (Chittenden et al.,
1995a; Simonen et al., 1997). A second subgroup contains pro-
apoptotic molecules structurally related by the presence of only
one family domain corresponding to BH3. Members of this
subfamily are thus known as BH3-only proteins (Bouillet and
Strasser,  2002). The third subgroup includes anti-apoptotic
homologues like Bcl-2 and Bcl-X
 
L
 
, and a distinct structural
feature is the presence of a BH4 domain in addition to BH do-
mains 1, 2, and 3 (Adams and Cory, 1998; Reed, 1998). Bcl-2
family proteins have a propensity to dimerize, and the fine bal-
ance between pro-and anti-apoptotic members often defines
whether a cell will survive or will commit to death in response to
a particular insult (Reed, 1998; Danial and Korsmeyer, 2004).
Current knowledge about apoptotic signaling cascades
supports the view that BH3-only molecules initiate the path-
way, activating downstream effectors Bak and Bax to trigger
mitochondrial apoptosis (Bouillet and Strasser, 2002). According
to this model, apoptotic insults unleash BH3-only homologues
and induce their translocation to the outer mitochondrial mem-
brane (Bouillet and Strasser, 2002). Once in the mitochondria,
these proteins are thought to bind preferentially anti-apoptotic
members of the family (Cheng et al., 2001; Zong et al., 2001;
Letai et al., 2002), saturating protective binding sites before
they bind and activate Bak and Bax. This direct engagement of
Bak and Bax has been established for BH3-only members
BimEL and Bid (Desagher et al., 1999; Wei et al., 2000; Letai
et al., 2002). Other homologues, like Bik or Bad, bind anti-
apoptotic molecules only, thus exerting a sensitization effect
(Letai et al., 2002). Activation of Bak and Bax involves modifi-
cations in their conformation (Hsu and Youle, 1997; Desagher
et al., 1999; Griffiths et al., 1999) and assembly into oligomers
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(Eskes et al., 2000; Wei et al., 2000). These changes ultimately
result in the release of mitochondrial apoptogenic factors into
the cytoplasm, thus irreversibly launching the death process
(Green and Reed, 1998; Danial and Korsmeyer, 2004).
Recently, Bak and Bax were shown to be essential for
multiple apoptotic pathways (Cheng et al., 2001; Wei et al.,
2001; Zong et al., 2001). In addition, both effectors show a
substantial functional redundancy because cells deficient in
only one of them remain sensitive to a variety of apoptotic
stimuli. Consistent with this, mice deficient in either protein
show mild phenotypes (Knudson et al., 1995; Lindsten et al.,
2000), whereas animals deficient in both of them suffer major
abnormalities (Lindsten et al., 2000). However, specific roles
for Bak and Bax can be found in the literature. Some publica-
tions refer to a more prominent involvement of Bax in multiple
cell death pathways in human cells (Zhang et al., 2000; The-
odorakis et al., 2002; Gillissen et al., 2003), whereas other re-
ports describe a fundamental role for Bak in cell death induced
by anticancer drugs (Wang et al., 2001a) or granzyme B (Wang
et al., 2001b). Additional differences relate to their subcellular
localization. In healthy cells, Bax is mainly a soluble protein
(Suzuki et al., 2000) that stably associates with intracellular
membranes upon an apoptotic insult (Hsu et al., 1997). On the
contrary, Bak is permanently inserted into subcellular mem-
branes and does not change its localization during apoptosis
(Griffiths et al., 1999). Although these differences could reflect
a differential regulation of pathways common to Bak and Bax,
they may also suggest the existence of biological activities ex-
clusively performed by each one of these molecules, which, for
the most part, have not been described.
Both Bak and Bax are also localized in the ER (Nutt et
al., 2002; Zong et al., 2003), an organelle that constitutes one
Figure 1. Coexpression of Bak and Bcl-XL induces cytoplasmic vacuolization. (A) Confocal analysis of cytoplasmic vacuolization induced by coexpression
of Bak and Bcl-XL. 293T cells were transfected with a mix of the indicated expression plasmids in combination with a plasmid expressing cytosolic GFP. 36 h
after transfection, cells were fixed, mounted, and analyzed by confocal microscopy. (B) Time course of vacuolization induced by coexpression of Bak
and Bcl-XL. 293T cells were cotransfected with Bak, Bcl-XL, and GFP as in A. At the indicated time points the proportion of GFP-expressing cells showing a
detectable level of cytoplasmic vacuolization was determined in vivo by blindly counting green cells under an inverted fluorescence microscope. At least
400 cells were scored for each experimental point. Columns represent the percentage of GFP-expressing cells showing a vacuolated cytoplasm. Error bars
show SDs of percentages obtained by counting at least eight different fields. (C) Quantitation of cells showing cytoplasmic vacuolization after transfection
with Bak or Bax in combination with Bcl-XL. 293T cells were transfected as in A, and analyzed as in B, 36 h after transfection. (D) Confocal analysis of
cytoplasmic vacuolization induced by Bak and Bcl-XL in different cell types. The indicated cells were transfected with the same mix of plasmids as in A. 24 h
(293T, as indicated) or 36 h (293T, HeLa, and Cos) later, cells were fixed, stained with DAPI, and mounted for confocal analysis. (E) Bcl-XL inhibits Bak
and Bax-induced apoptosis to the same extent. 293T cells were transfected with the indicated expression plasmids. 24 h after transfection, cells were lysed
and equal amounts of proteins were subjected to Western blotting using an anti-PARP antibody. (F) AU-Bak and AU-Bax are expressed to comparable
levels. 293T cells were transfected as in E with the exception that a vector expressing the viral caspase inhibitor p35 was introduced in all experimental
points to block death. 24 h after transfection, cells were lysed and equal amounts of proteins were resolved by PAGE and blotted with an anti-AU mAb. 
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of the main calcium storages in the cell (Rizzuto et al., 2003).
In fact, these effectors partially control apoptosis by regulating
ER calcium levels (Breckenridge et al., 2003; Rizzuto et al.,
2003). For example, Bak and Bax-deficient mouse embryonic
fibroblasts (MEFs) show a reduced ER calcium concentration
and a concomitant decreased response to apoptotic stimuli that
use ER calcium for intracellular signaling (Scorrano et al.,
2003). In turn, Bak and Bax expression promotes calcium re-
lease from ER stores thus leading to cell death (Nutt et al.,
2002; Zong et al., 2003). Therefore, like in mitochondria, activ-
ities ascribed so far to Bak and Bax in the ER seem quite over-
lapping. In any event, the role of Bcl-2-family members in re-
ticular cisternae has only recently been addressed, and the full
scope of their functions in this compartment is probably far
from complete.
Here, we describe a novel activity of Bak in the ER.
When coexpressed with Bcl-X
 
L
 
, Bak is able to induce dramatic
conformational alterations and swelling of reticular cisternae.
Due to an inhibitory function performed by ryanodine receptor
(RyR) calcium channels, this phenomenon remains undetected
if the signaling pathway is stimulated by upstream BH3-only
activators. However, blockade of RyR activity by pharmaco-
logical agents reveals this underlying activity as a profuse ER
swelling and vacuolization whose induction requires the en-
dogenous expression of Bak. Interestingly, we find that Bax
completely lacks this potential, indicating that the two multido-
main homologues may not always carry out a completely over-
lapping range of cellular activities.
 
Results
 
Previous reports indicate that the enforced expression of Bak
and Bax triggers spontaneous cell death (Chittenden et al.,
1995b; Xiang et al., 1996), an activity opposed by anti-apop-
totic homologues like Bcl-X
 
L
 
 (Chittenden et al., 1995a; Simo-
nen et al., 1997). To look for functional differences between
Bak and Bax we took advantage of this overexpression ap-
proach, and transfected both molecules under various condi-
tions into 293T cells. A striking difference arose when the
induced apoptotic process was inhibited by Bcl-X
 
L
 
. Simulta-
neous expression of Bak and Bcl-X
 
L
 
 provoked a prominent cy-
toplasmic vacuolization revealed by the exclusion of cytosolic
GFP (Fig. 1 A), whereas this phenotype was absent in cells co-
expressing Bax and Bcl-X
 
L
 
 (Fig. 1 A). Time course experi-
ments showed that the effect was first detectable between 12
and 16 h after transfection (Fig. 1 B), peaking at around 36 h
after transfection (Fig. 1 B). At this time point there was no de-
tectable vacuolization in cells transfected with Bax in the pres-
ence of Bcl-X
 
L
 
, Bcl-X
 
L
 
 alone, or empty vector (Fig. 1 C). At
later times cells lost viability as evidenced by an increased per-
meability to propidium iodide (unpublished data), a death pro-
cess that progressed without detectable caspase-dependent pro-
teolytic processing of poly(ADP-ribose) polymerase (PARP;
unpublished data). This vacuolating capacity of Bak and Bcl-
X
 
L
 
 was independent of the cell type, because different cell lines
were similarly susceptible (Fig. 1 D). DNA staining with DAPI
showed that at least one prominent cytoplasmic vacuole was
usually localized in close contact with the periphery of the nu-
cleus (Fig. 1 D). The different potential of transfected Bak and
Bax in this assay was not due to a dissimilar inhibitory capabil-
ity of Bcl-X
 
L
 
, because the proteolytic processing of PARP was
equally blocked by Bcl-X
 
L
 
 in both cases (Fig. 1 E). In addition,
no significant differences in Bak and Bax expression levels
could account for the observed phenomena (Fig. 1 F).
Because Bak overexpression triggers efficient death (Fig.
1 E; Chittenden et al., 1995b), it is possible that the generation
of cytoplasmic vacuolae is a simultaneous phenomenon nor-
mally obscured by the dominant apoptotic activity. In this sce-
nario, cotransfected Bcl-X
 
L
 
 would reveal the phenotype by
simply inhibiting cell death. A prediction of this model is that
Figure 2. Inhibition of Bak-induced apoptosis is not sufficient to reveal
cytoplasmic vacuolization. (A) Quantitation of vacuolated cells after trans-
fection with Bak in the presence of different apoptotic inhibitors. 293T
cells were transfected with a mix of the indicated plasmids and a GFP-
expressing plasmid. C9.DN and p35 denote a dominant-negative version
of caspase-9 and the viral caspase inhibitor p35, respectively. When indi-
cated, the pan-caspase inhibitor z-VAD.fmk (100  M) was added 1 h after
transfection. Cytoplasmic vacuolization was scored as in Fig. 1 B. (B)
Death inhibitors unable to reveal vacuolization block Bak apoptosis to the
same extent as Bcl-XL. 293T cells were transfected with a mix of the indi-
cated expression plasmids. Z-VAD.fmk (100  M) was added 1 h after
transfection. Cells were lysed 24 h after transfection. Shown are blots
probed with anti-PARP (top) and anti-AU (bottom) antibodies. The latter
confirms equal transfection efficiency. (C) Quantitation of cells showing
cytoplasmic vacuolization after transfection with Bak and Bcl-XL in the
presence of different inhibitors of apoptosis. 293T cells were transfected
and treated as in A, and scored as in Fig. 1 B. 
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Bak expression should induce vacuolization in the presence of
alternative blockers of apoptosis. However, treatment with dif-
ferent caspase inhibitors was not sufficient to reveal the pheno-
type in Bak-transfected cells (Fig. 2 A), although all tested
reagents suppressed PARP processing to the same extent as
Bcl-X
 
L
 
 did (Fig. 2 B). While this result could also indicate that
caspases are necessary for vacuolization, caspase inhibition
during coexpression of Bak and Bcl-X
 
L
 
 did not reduce the pro-
portion of vacuolated cells (Fig. 2 C), ruling out a role for these
proteases in the observed phenomenon. Together, these data
show that Bak normally lacks the capability of inducing cyto-
plasmic vacuolization, and suggest the need for an activation
step provided by Bcl-X
 
L
 
. Alternatively, Bcl-X
 
L
 
, and not Bak,
could be the effector molecule in this context.
Bcl-X
 
L
 
 has been shown to bind and inhibit Bak and
Bax BH3 domains, thus antagonizing their apoptotic activities
(Chittenden et al., 1995a; Simonen et al., 1997). Therefore, the
capacity of Bcl-X
 
L
 
 to reveal the vacuolating potential of Bak
might as well involve BH3 domain inhibition. To test this pos-
sibility, we created a deleted version of Bak lacking the BH3
domain (Bak-
 
 
 
BH3) and evaluated its ability to induce the ob-
served phenomenon in the absence of Bcl-X
 
L
 
. Transfection ex-
periments indicated that this Bak mutant has an autonomous
ability to induce cytoplasmic vacuolization (Fig. 3 A). Quanti-
tation studies showed only a slight decrease in the percentage
of vacuolated cells compared with cultures transfected with
Bak and Bcl-X
 
L
 
 (Fig. 3 B). Both Bak versions were expressed
to similar levels (Fig. 3 C). These data confirm that Bak, and
not Bcl-X
 
L
 
, is the active molecule in this context, and suggest
that Bcl-X
 
L
 
 reveals this function by binding and inactivating
the BH3 domain of Bak.
Interestingly, additional deletion of the BH1 domain
blocked the vacuolating activity of Bak-
 
 
 
BH3 (Fig. 3 B) with-
out affecting its expression level (Fig. 3 C) or intracellular dis-
tribution (unpublished data). This result suggests a role for Bak
BH1 domain in inducing the phenotype. In addition, because
both Bak versions (Bak-
 
 
 
BH3 and Bak-
 
 
 
BH3-
 
 
 
BH1) pro-
voked a comparable loss of cell viability at late time points
(measured by propidium iodide permeability; unpublished data),
cytoplasmic vacuolization is probably not an epiphenomenon
linked to this delayed death.
ER swelling is a morphological change associated with
multiple cell death modalities (Van Cruchten and Van Den
Broeck, 2002). To determine if vacuolae were topologically re-
lated to reticular cisternae, we created a version of RFP tar-
geted to the ER lumen (erRFP). Control experiments estab-
lished that erRFP completely colocalized with the ER marker
calreticulin in normal cells (Fig. 4 A). Transfection of Bak in
the presence of Bcl-X
 
L
 
, or Bak-
 
 
 
BH3 alone, in combination
with this construct showed that the induced vacuolae were
completely filled with erRFP, clearly establishing their reticu-
lar origin (Fig. 4 B). A substantial fraction of the ER remained
unchanged at early stages of the swelling process (Fig. 4 B,
293T cells, 24 h), but reticular cisternae seemed to be progres-
sively incorporated into the altered structures as transfection
evolved (Fig. 4 B). These results reveal the potential of Bak to
regulate ER structure. Because vacuolae can often occupy a
substantial area of the cell, their generation likely involves a
swelling process, although some contribution of ER tubulae fu-
sion cannot be ruled out.
To determine the subcellular localization of transfected
Bak with respect to dilated ER cisternae we used AU-tagged
versions of the different molecules. Anti-AU immunofluores-
cence stainings of cells transfected with AU-Bak in combina-
tion with untagged Bcl-X
 
L
 
, or AU-Bak-
 
 
 
BH3 alone, revealed
that vacuolae were often coated with a punctated pattern of AU
reactivity (Fig. 5 A). This was particularly obvious in areas of
Figure 3. A version of Bak lacking the BH3 domain induces cytoplasmic
vacuolization in the absence of cotransfected Bcl-XL. (A) Confocal analysis
of cytoplasmic vacuolization induced by expression of Bak- BH3. 293T
cells were transfected with a mix of plasmids expressing Bak- BH3 and
GFP. Cells were fixed, mounted, and analyzed by confocal microscopy
24 or 36 h (as indicated) after transfection. (B) Quantitation of vacuolization
in cells transfected with Bak- BH3 or Bak- BH3- BH1. 293T cells were
transfected with the indicated plasmids, along with a GFP-expressing
plasmid. 36 h later the proportion of GFP-expressing cells showing vacu-
olization was determined as in Fig. 1 B. (C) AU-Bak, AU-Bak- BH3, and
AU-Bak- BH3- BH1 are expressed to comparable levels. 293T cells were
transfected, lysed, and processed as in Fig. 1 F. Shown is a Western blot
probed with an anti-AU antibody. 
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direct apposition with the nucleus (Fig. 5 A). A variation of the
same experiment showed a similar distribution of Bcl-X
 
L
 
 (Fig.
5 A). These results indicate the existence of a topological link
between effector molecules and swollen cisternae.
This idea was also supported by experiments where we
artificially targeted Bak-
 
 
 
BH3 to different subcellular com-
partments. A chimeric version of Bak-
 
 
 
BH3 (Bak-
 
 
 
BH3-cb5)
containing the transmembrane region of cytochrome b5, previ-
ously shown to confer exclusive ER targeting (Zong et al.,
2003), fully retained the capacity to induce vacuolization (Fig.
5 B). In contrast, a form of Bak-
 
 
 
BH3 fused to the ActA pep-
tide, which induces mitochondrial localization (Bak-
 
 
 
BH3-
Figure 4. Cytoplasmic vacuolae are swollen ER cisternae. (A) Colocalization of erRFP with endogenous calreticulin. 293T cells were transfected with a
plasmid encoding ER-targeted RFP (erRFP). 48 h later cells were fixed and stained with an anti-calreticulin antibody followed by an Alexa 488 (green)–
coupled antibody, and analyzed by confocal microscopy. Shown is one representative example. (B) Vacuolae induced by transfection of Bak and Bcl-XL,
or Bak- BH3, are filled with coexpressed erRFP. 293T, Cos, and HeLa cells were cotransfected with the indicated constructs and plasmids expressing GFP
and erRFP. 24 h (293T cells, as indicated), or 48 h after transfection, cells were analyzed in vivo by confocal microscopy. Live cells were used since fixation
resulted in the disappearance of erRFP fluorescence from vacuolae in mounted preparations. White arrows indicate reticular cisternae that remain unaffected
at early time points in 293T cells. 
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ActA; Zhu et al., 1996), showed a decreased activity (Fig. 5 B).
Control immunostaining assays indicated that a portion of Bak-
 
 
 
BH3-ActA was surprisingly present in reticular membranes,
as established by colocalization with calreticulin (unpublished
data). This result suggests that human Bak may have additional
ER targeting signals able to override ActA. Given this partially
reticular localization, Bak-
 
 
 
BH3-ActA should not be expected
to be completely incapable of inducing ER vacuolization, even
if only reticular Bak is active in this context. The localization
of the cb5 chimera was tightly reticular (unpublished data). To-
gether, these results further underscore the notion that the abil-
ity of Bak to induce vacuolization is linked to its physical pres-
ence in the ER.
High calcium levels in the cytoplasm have been shown to
induce ER compartmentalization and vacuolization (Subrama-
nian and Meyer, 1997), pointing out to a role of calcium in the
regulation of ER structure. Because Bcl-2 family members
have the ability to alter ER calcium homeostasis (Nutt et al.,
2002; Scorrano et al., 2003; Zong et al., 2003), the observed re-
ticular swelling induced by Bak might be related to this activ-
ity. To test this hypothesis we used chemicals that influence
calcium homeostasis in different ways. Chelation of extracellu-
lar calcium by EGTA, or treatment with the SERCA pump in-
hibitor thapsigargin, which allows a passive calcium leakage
from ER stores (Breckenridge et al., 2003), had no effect in the
degree of vacuolization (unpublished data). Dantrolene is a
commercial drug that inhibits ER calcium release through the
RyR calcium channels (Zhao et al., 2001; Fill and Copello,
2002). This drug has been shown to reduce the cytosolic con-
centration of calcium in some systems (Jacobs et al., 1991).
The presence of dantrolene during expression of transfected
Bak and Bcl-X
 
L
 
, or Bak-
 
 
 
BH3 alone, had the unexpected ef-
fect of exacerbating the vacuolated phenotype (Fig. 6 A). Vac-
uolae tended to occupy the vast majority of cytoplasmic space
in the presence of dantrolene, whereas in its absence they were
typically smaller (Fig. 6 A). In contrast, no change was ob-
served in the cytoplasm of cells cotransfected with Bax and
Bcl-X
 
L
 
 or either Bak or Bax in the presence of apoptotic block-
ers like the caspase inhibitor p35 or a dominant-negative ver-
sion of caspase-9 (unpublished data). This suggests that dan-
trolene only shows an effect in the presence of an underlying
vacuolating stimulus.
Results obtained with dantrolene argue that the observed
reticular changes are partially countered by the activity of RyR
channels. If this model is true, RyR activation should provoke a
reduction of vacuolae size. Among other cellular effects, caf-
feine activates these channels thus allowing the release of cal-
cium from ER stores (Ozawa, 2001). Treatment of vacuolated
cells with caffeine induced a prompt reduction of vacuolae size
(unpublished data), and resulted in a lower number of cells pre-
senting a detectable phenotype (Fig. 6 B). Together, these data
support a role for RyR calcium channels in regulating Bak-
induced ER structural changes and, as a consequence, suggest
an involvement of calcium.
Figure 5. Involvement of ER-localized Bak in
the generation of reticular swelling. (A) Peri-
vacuolar localization of AU-Bak, AU-Bcl-XL,
and AU-Bak- BH3. 293T cells were trans-
fected with the indicated constructs along with
GFP. 36 h after transfection cells were fixed,
stained with an anti-AU mAb followed by an
anti–mouse-Cy3 (red) antibody, and mounted
for confocal microscopy. N and V denote
nuclei and vacuolae, respectively. (B) A ver-
sion of Bak- BH3 specifically targeted to the
ER (Bak- BH3-cb5) retains the capacity to in-
duce ER swelling, whereas mitochondrial tar-
geting (Bak- BH3-ActA) results in a decreased
activity. 293T or HeLa cells (as shown) were
transfected with the indicated expression plas-
mids along with GFP. Z-VAD.fmk (100  M)
was added 1 h after transfection to reduce
death. 36 h after transfection, cytoplasmic
vacuolization was scored as in Fig. 1 B. 
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To explore this idea, we compared calcium concentrations
inside vacuolae with those in normal ER. For this purpose, we
cotransfected Bak and Bcl-X
 
L
 
 along with an ER-targeted ver-
sion of the ratiometric, low affinity calcium indicator yellow
cameleon 3.3 (erYC3.3; Miyawaki et al., 1997) and RFP for
identification of vacuolated cells. YC3.3 responds to changes
in calcium concentrations by altering its spectral properties
due to an intramolecular fluorescence resonance energy transfer
(FRET) effect (Miyawaki et al., 1997). Confocal FRET mea-
surements revealed that intensities inside swollen ER were simi-
lar to those present in unswollen cisternae of transfected neigh-
boring cells (Fig. 6 C, top and middle). Comparable FRET
levels were obtained when the erYC3.3 reporter was cotrans-
fected with an irrelevant vector (Fig. 6 C, bottom). Treatment
with EGTA and thapsigargin reduced FRET intensities in both
dilated and normal ER (Fig. 6 D), thus confirming the capacity
of erYC3.3 to detect calcium variations. These results indicate
that calcium concentrations present in swollen ER are similar to
those in unaltered cisternae. Additional experiments showed no
changes in cytoplasmic calcium induced by coexpression of Bak
and Bcl-X
 
L
 
, or Bak-
 
 
 
BH3 (unpublished data), measured at dif-
ferent times after transfection with the cytoplasmic, low affinity
ratiometric indicator YC2.3 (Miyawaki et al., 1997).
This lack of correlation between reticular swelling and
calcium variations, along with the inability of thapsigargin or
EGTA to influence vacuolization (unpublished data), argue
against a direct involvement of calcium in this phenomenon.
Data showing an effect by dantrolene and caffeine suggest a
model in which Bak-induced ER remodelling is countered by
cytosolic calcium specifically mobilized by RyR channels.
Bak and Bax are physiologically activated by BH3-only
homologues like BimEL or Bid (Bouillet and Strasser, 2002).
To explore if these upstream effectors are capable of generat-
ing a vacuolated phenotype, we transfected cells with plasmids
Figure 6. Involvement of RyR calcium channel activity in the regulation of cytoplasmic vacuolization induced by Bak. (A) Treatment with dantrolene potentiates
vacuolization. 293T cells were transfected with a mix of the indicated plasmids and a plasmid expressing GFP. Where indicated, dantrolene (50  M) was
added 1 h after transfection. 36 h after transfection, cells were fixed, mounted, and analyzed by confocal microscopy. Shown are representative fields. The
same magnification was used for both control and treated cells. (B) Caffeine treatment reduces vacuolization. 293T cells were transfected as in A. 36 h later,
caffeine (20 mM) was added as indicated for 3.5 h, and cells were subsequently fixed and mounted. Quantitation of vacuolated cells was done as in Fig. 1
B. (C) Swollen ER cisternae and normal ER show similar calcium concentrations. 293T cells were transfected with the indicated plasmids in the presence of
plasmids expressing cytosolic RFP and a reticular ratiometric calcium indicator (erYC3.3). 36 h after transfection, cells were analyzed in vivo by confocal
microscopy to obtain FRET intensities of erYC3.3. In the top panel, RFP was used to locate a vacuolated cell in proximity to an unvacuolated neighbor with
a similar level of transfection, and emission FRET ratios (535 nm/480 nm) were obtained for both cells. Shown are emissions in red (RFP), green (erYC3.3,
535 nm), and FRET ratios. The middle panel shows a profile of FRET intensities across the indicated yellow line, including both vacuolated (Vacuole)
and unvacuolated (Normal) ER. The bottom panel shows a profile of ER FRET intensities of a cell transfected with an irrelevant vector and presenting similar
erYC3.3 expression levels as cells in the top panel (measured by emission at 535 nm). (D) Treatment with thapsigargin and EGTA reduces erYC3.3 FRET
intensities both in swollen and unaltered ER. 293T cells were cotransfected with Bak, Bcl-XL, and erYC3.3. 36 h after transfection, both unvacuolated (Normal)
and vacuolated (Vacuolae) cells were analyzed in vivo to obtain confocal FRET levels in the ER. After capturing FRET images for each untreated cell, 2 mM
EGTA and 200  M thapsigargin were simultaneously added to the culture, and reticular FRET images acquired after 15 min. This time point showed the
maximum effect. To represent the data, mean values of FRET intensities across a chosen section of the ER were obtained for each cell in control and treated
conditions. Shown are data averaged for at least five cells analyzed in each experimental condition, along with the corresponding SDs. 
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expressing either full-length BimEL or a truncated version of
Bid (tBid) known to be constitutively active (Li et al., 1998).
Coexpression of BimEL or tBid with Bcl-X
 
L
 
 induced a low but
detectable number of cells (
 
 
 
1%) to show cytoplasmic vacu-
olae (unpublished data), suggesting an incipient ER swelling.
Given the potentiating effect of dantrolene (Fig. 6 A), we won-
dered if the drug could turn this weak effect into a vacuolated
phenotype easier to identify. The presence of dantrolene from
early on after transfection with BimEL or tBid in combination
with Bcl-X
 
L
 
 resulted in a substantial number of vacuolated
cells (Fig. 7 A), whereas in the absence of Bcl-X
 
L
 
 both mole-
cules induced a more modest phenotype (Fig. 7 A). Cotransfec-
tion with erRFP confirmed the reticular origin of the induced
vacuolae (Fig. 7 B). Therefore, upstream apoptotic activators
can cause ER changes that remain undetectable with the tech-
niques used unless amplified by inhibition of RyR channels. In
light of our previous results this effect could be mediated by
endogenous Bak, which, consistent with this model, is present
in 293T cells (Fig. 7 C).
To test this possibility, we turned to 
 
bak
 
 
 
/
 
 
 
 and 
 
bax
 
 
 
/
 
 
 
MEFs. Reminiscent of previous results with 293T cells (Fig. 7
A), transfection of BimEL or tBid in combination with Bcl-X
 
L
 
induced wild-type MEFs to show cytoplasmic vacuolization in
the presence of dantrolene (Fig. 8 A). Vacuolae had a reticular
origin as shown by experiments using cotransfected erRFP (un-
published data). Although this phenotype was basically un-
changed in Bax-deficient MEFs (Fig. 8 A), the absence of Bak
almost completely abolished it (Fig. 8 A). In addition, expres-
sion of Bak-
 
 
 
BH3 induced a comparable extent of cytoplasmic
vacuolization in all tested MEFs (Fig. 8 B), indicating that en-
dogenous full-length Bak is unnecessary for the activity of
Bak-
 
 
 
BH3. All these results point to a model where upstream
ER-remodelling signals are entirely transmitted through endog-
enous Bak, whereas Bax is for the most part inactive.
Figure 7. Coexpression of BimEL or tBid with Bcl-XL in-
duces ER swelling in the presence of dantrolene. (A)
Quantitation of dantrolene-treated cells showing cytoplas-
mic vacuolization after transfection with BimEL or tBid, as
a function of cotransfection with Bcl-XL. 293T cells were
transfected with a mix of the indicated constructs in the
presence of plasmids expressing GFP and the apoptotic
inhibitor p35. Dantrolene (50  M) was added 1 h after
transfection to all experimental points. 36 h later the pro-
portion of GFP-expressing cells showing cytoplasmic vac-
uolization was determined as in Fig. 1 B. (B) ER swelling
is the cause of cytoplasmic vacuolization induced by
cotransfection of BimEL or tBid with Bcl-XL, in the presence
of dantrolene. 293T cells were transfected with plasmids
expressing either Bim or tBid (as indicated), in combina-
tion with Bcl-XL, GFP, and erRFP expression plasmids.
Dantrolene (50  M) was added 1 h after transfection. 36 h
after transfection, cells were analyzed by in vivo confocal
microscopy. (C) 293T cells express endogenous Bak and
Bax. Cells were either transfected with the indicated
DNAs or left untransfected, and lysed 24 h after transfec-
tion. Shown are Western blots probed with antibodies
against Bak or Bax (top), and subsequently reprobed with
an anti-AU mAb (bottom) as indicated. Lanes correspond-
ing to transfected cells provide a size reference to identify
the endogenous protein. Re-probing with an anti-AU mAb
excludes sample contaminations across wells. 
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Discussion
 
Results presented here describe a previously unrecognized ac-
tivity of Bak in the ER. If activated by Bcl-X
 
L
 
, overexpressed
Bak induces swelling and vacuolization of ER cisternae. Endog-
enous Bak is also able to transmit similar signals when the path-
way is stimulated by upstream BH3-only activators. However,
in this case, ER changes are only detected as swollen cisternae
after blockade of RyRs, indicating an inhibitory function per-
formed by these calcium channels. Overexpression of signaling
effectors is a widely used strategy that often provides hints
about function, although excessive expression can lead to arti-
factual phenotypes. The fact that in our system endogenous Bak
can transmit ER changes initiated by BH3-only activators ar-
gues against an artifactual origin of the phenomenon induced by
coexpression of Bak and Bcl-XL. Together, these results point to
a relevant function of Bak in the regulation of ER structure.
Data shown here also argue that Bcl-XL can activate Bak
to acquire a new function. In this novel functional status, Bak
would have the capability to modulate reticular conformation,
while its natural pro-apoptotic potential remains inhibited.
However, previous reports suggest that these reticular changes
might also have death sensitization consequences. For exam-
ple, a Bak mutant lacking the BH3 domain, whose overexpres-
sion causes ER swelling in our hands, increases susceptibility
to cell death induced by chemotherapy agents (Simonian et al.,
1997), suggesting a link between both phenomena. Coinciden-
tally, a naturally existing BH3-minus Bak version is able to kill
cells if overexpressed (Kim et al., 2004). Furthermore, Bcl-XL
does not always block cell death, because in some systems it
redirects apoptosis to alternative forms of cell demise such as
necrosis (Shinoura et al., 1999). This is compatible with our
own unpublished results indicating that, after suffering ER
swelling, cells die in a nonapoptotic manner.
A substantial functional redundancy has been previously
reported for Bak and Bax. Thus, cells deficient for only one of
these mediators remain sensitive to multiple apoptotic induc-
ers, whereas double-deficient cells are widely resistant (Cheng
et al., 2001; Wei et al., 2001; Zong et al., 2001). In addition,
only double knockout mice present acute phenotypes (Knud-
son et al., 1995; Lindsten et al., 2000). Consistent with this
redundancy, an overlapping range of cellular activities has
been ascribed to these molecules. Both mediators induce mito-
chondrial apoptosis by inserting into the outer mitochondrial
membrane, by promoting their oligomerization, and ultimately
by allowing the release of cytochrome c from the intermem-
brane space (Cory et al., 2003). Similarly, both proteins medi-
ate ER-dependent apoptosis by inducing calcium release from
reticular cisternae (Nutt et al., 2002). Our results showing that
Bak has functions in the ER that are not shared by Bax suggest
that this functional similarity may not always apply.
Activities uniquely ascribed to Bak or Bax could help ex-
plain some of the discrepancies found in the literature. Thus,
despite a high degree of functional redundancy, only Bak is
critical for apoptosis induced by chemotherapy drugs (Wang et
al., 2001a) or granzyme B (Wang et al., 2001b), whereas Bax
has a predominant role in other models (Zhang et al., 2000;
Theodorakis et al., 2002; Gillissen et al., 2003). If cell-type or
context-dependent cues can increase the relative importance of
specific Bak and Bax activities with respect to common BH3-
dependent pathways, this could explain why in some systems
one molecule can be present but inactive whereas its counter-
part is fully functional in transmitting death signals.
The accepted model for mitochondrial apoptosis places
BH3-only molecules upstream of Bak and Bax in the signal-
ing cascade (Bouillet and Strasser, 2002). We find that this
epistatic sequence is maintained in the function of Bak that
we describe here. However, how BH3-only molecules acti-
vate Bak to carry out a function that needs an additional acti-
vation step provided by Bcl-XL poses some challenges. This
Figure 8. Effect of endogenous Bak and Bax in cytoplasmic vacuolization.
(A) Bak-deficient MEFs are unable to generate ER swelling in response to
coexpression of BimEL or tBid with Bcl-XL in the presence of dantrolene.
The different MEFs were transfected with a mix of the indicated plasmids
and a plasmid expressing GFP. Transfection efficiencies ranged between
20 and 30%. Dantrolene (50  M) was added 1 h after transfection to all
wells. Z-VAD.fmk (100  M) was also added 1 h after transfection to re-
duce background death. 48 h later the proportion of GFP-expressing cells
showing cytoplasmic vacuolization was determined as in Fig. 1 B. Shown
is one representative example of three independent experiments. (B) Ex-
pression of Bak- BH3 induces cytoplasmic vacuolization irrespective of
the endogenous expression of Bak or Bax. MEFs were cotransfected with
the indicated plasmids and a plasmid expressing GFP. Transfection, treat-
ments and scoring were done as in A.JCB • VOLUME 168 • NUMBER 5 • 2005 732
Bak-associated activity likely requires the formation of Bak–
Bcl-XL complexes. Support for this notion comes from our
data showing that the vacuolating potential of Bak is un-
masked by deletion of the BH3 domain, precisely the region
that Bcl-XL is known to bind and inhibit (Chittenden et al.,
1995a). But in order to expose its BH3 domain and bind Bcl-
XL, Bak has to undergo a structural shift (Sattler et al., 1997),
a change thought to be directly induced by BH3-only mem-
bers Bim or tBid (Desagher et al., 1999; Wei et al., 2000; Le-
tai et al., 2002). Therefore, the probable signaling logic in our
system is that BH3-only proteins activate Bak to expose its
BH3 domain for binding by Bcl-XL. However, Bim and tBid
are known to preferentially bind anti-apoptotic molecules, sat-
urating protective sites before they activate Bak and Bax
(Zong et al., 2001; Cheng et al., 2001; Letai et al., 2002). Ob-
viously, this makes it difficult for activated Bak to find Bcl-
XL molecules not previously occupied by BH3-only homo-
logues. A plausible solution comes from reports showing that
Bcl-XL is mainly a soluble protein that translocates to mem-
brane fractions on apoptosis (Hsu et al., 1997). These data
open the possibility that empty Bcl-XL molecules become
available in the ER after Bak activation has occurred.
In addition, the activity described here may involve the
formation of a molecular complex simultaneously including
BH3-only homologues, Bak and Bcl-XL. Although Bak is
thought to mainly function as a BH3-domain donor, it contains
a pocket that can be recognized by the BH3 domain of Bim and
Bid (Letai et al., 2002). Whether Bak can bind at the same time
BH3-only molecules and Bcl-XL is an interesting possibility
that remains to be investigated.
Although the underlying biochemical nature of ER swell-
ing in our system is unclear, a reasonable possibility is that it
is due to an increased osmotic pressure caused by an inward
ionic current. Because Bak has been shown to regulate ER cal-
cium levels (Nutt et al., 2002; Scorrano et al., 2003; Zong et
al., 2003), this ion could be involved. However, several lines
of evidence argue against a direct role of calcium. First, Bax
has been shown to regulate reticular calcium in the same man-
ner as Bak (Nutt et al., 2002; Scorrano et al., 2003), and it is
difficult to imagine how a Bak-specific function could be me-
diated by a common regulatory activity. Second, our own un-
published data indicate that treatment with thapsigargin (an
agent that reduces ER calcium levels) does not influence vacu-
olae formation. Third, we have seen that calcium concentra-
tions both inside vacuolae and in the cytosol remain un-
changed in vacuolated cells.
Although calcium is unlikely to be directly involved, re-
sults showing that ER swelling is potentiated by dantrolene and
inhibited by caffeine point to a regulatory role by RyR chan-
nels. Because dantrolene and caffeine respectively reduce (Ja-
cobs et al., 1991) and increase (Ozawa, 2001) cytosolic cal-
cium, a plausible model is that calcium specifically released by
RyRs has the ability to counter the reticular alterations. In addi-
tion, it is interesting to note that, although reasonably selective,
RyR channels are known to allow passage of other cations (Fill
and Copello, 2002), thus raising the possibility that an ion other
than calcium is involved in the described phenomena.
Other more trivial mechanisms are less likely to occur.
For example, it has been described that insertion of the COOH-
terminal tail-anchor of cytochrome b5 into reticular mem-
branes causes ER conformational changes in yeast (Vergeres et
al., 1993). The fact that deletion of the BH1 domain blocks this
process excludes that Bak is unspecifically causing ER struc-
tural changes as a consequence of a similar phenomenon.
In summary, we describe here a novel cellular activity
that can be unequivocally performed by Bak but not Bax. This
exclusive function could explain why in some systems the
functional redundancy that has been ascribed to both molecules
does not apply. More generally, it provides some insight into
the role of multidomain pro-apoptotic effectors in the ER, an
organelle whose involvement in the regulation of cell death is
just beginning to be dissected.
Materials and methods
Cell lines and reagents
293T, HeLa, and Cos cells were obtained from the American Type Culture
Collection. S. Korsmeyer (Harvard Medical School, Boston, MA) provided
the wild-type and Bak or Bax-deficient transformed MEFs (Wei et al.,
2001). Cells were cultured at 37 C and a humidified 5% CO2 atmo-
sphere, in DME (Invitrogen) containing 10% heat-inactivated FBS (Invi-
trogen) and 100 U/ml of penicillin/streptomycin (Invitrogen). Caffeine,
dantrolene, EGTA, and thapsigargin were obtained from Sigma-Aldrich.
Z-VAD.fmk was obtained from Becton Dickinson.
DNA constructs and transfections
Bak, Bax, BimEL, and tBid cDNAs were amplified by PCR from a human
primary T cell cDNA library. All cDNAs were verified by sequencing, con-
tained the same gccaccatg Kozak consensus for initiation of translation,
and were cloned into the pEAK series of mammalian expression plasmids
(Edge Biosystems). The Bcl-XL construct was described elsewhere (Pimentel-
Muiños and Seed, 1999). The caspase-9-dominant negative (C9.DN) and
p35 expression plasmids (Rabizadeh et al., 2004) were provided by S.
Rabizadeh (The Buck Institute for Age Research, Novato, CA). Bak- BH3
was constructed by PCR, substituting the BH3 domain (amino acids 72–
88, both deleted) for an EcoR1 site, which introduces amino acids EF in-
stead. To create Bak- BH3- BH1, PCR was used to substitute the BH1 do-
main (amino acids 117–136) for a BamH1 site (amino acids GS). PCR
was also used to generate both Bak- BH3-cb5 and Bak- BH3-ActA con-
structs. In brief, the previously described cb5 reticular (Zong et al., 2003)
and ActA mitochondrial (Zhu et al., 1996) localization signals were in-
serted downstream amino acid 186 of human Bak- BH3, using an engi-
neered BbsI site. Template constructs containing mouse Bak-cb5 and
human Bcl2-ActA were provided by C. Thompson (University of Pennsylva-
nia, Philadelphia, PA) and D. Andrews (McMaster University, Hamilton,
Canada), respectively. cDNAs were tagged at the NH2 terminus by insert-
ing the relevant PCR product downstream of a sequence encoding the
AU1 peptide (DTYRYI). Constructs used in figures where AU tagging is
essential (Figs. 1 F, 2 B, 3 C, 5 A, and 7 C) are labeled as such. All other
results were reproduced with both tagged and untagged versions. ER-tar-
geted RFP was created by PCR to introduce the COOH-terminal amino
acid sequence SEKDEL, able to confer ER retention to heterologous pro-
teins (Munro and Pelham, 1987). This fragment was ligated downstream
the leader sequence of the surface molecule CD5, and cloned into the
pEAK vector. A similar approach was used to build the ER-targeted ver-
sion of the low affinity calcium indicator YC3.3 (Miyawaki et al., 1997),
which was provided by R. Tsien (University of California, San Diego, La
Jolla, CA).
Transfections of 293T cells were performed using the calcium phos-
phate precipitation method (Ausubel et al., 1987). DNA amounts were 1
 g for 24-well plates and 5  g for 6-well plates. HeLa, Cos, and MEFs
were always transfected in 24-well plates using Fugene (Roche) liposomes
combined with 0.4  g of DNA.
Immunofluorescence stainings, microscopy, and FRET analysis
In vivo quantitation of vacuolated cells and immunofluorescence studies
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were seeded onto poly-L-lysine (293T; Sigma-Aldrich) or tissue culture-
treated (for Cos and HeLa cells; Fisher Scientific) coverslips, and trans-
fected the next day. At the end of the experiment, coverslips were fixed in
4% PFA (Sigma-Aldrich). For DAPI and antibody stainings, cells were per-
meabilized in PBS containing 0.5% Igepal CA-630 detergent (Sigma-Aldrich)
and 1% glycine to block free aldehyde groups. To stain with DAPI, an ad-
ditional incubation in PBS with 1  g/ml DAPI (Roche) was performed. For
antibody stainings, preparations were blocked in 3% BSA diluted in PBS
and stained for 1 h with an anti-AU1 mAb (2  g/ml; Babco), or a poly-
clonal rabbit anti-calreticulin serum (1/100; Calbiochem). The respective
secondary stainings were performed for 1 h using a 1/400 dilution of a
Cy3-coupled goat anti–mouse serum (Jackson ImmunoResearch Laborato-
ries) or an Alexa Fluor 488 goat anti–rabbit serum (Molecular Probes).
Cells were mounted in medium containing Mowiol 4-88 (Calbiochem) pre-
pared as described previously (Harlow and Lane, 1988).
Cytoplasmic vacuolization was usually scored in vivo under an in-
verted fluorescence microscope (Axiovert 135; Carl Zeiss MicroImaging,
Inc.) using the 20  objective. For confocal studies we used the 488- and/
or 543-nm bands of the Argon and Helium-Neon lasers, respectively, of a
confocal microscope (model LSM-510; Carl Zeiss MicroImaging, Inc.). Im-
ages were imported using the LSM-510 software (Carl Zeiss MicroImag-
ing, Inc.). For in vivo confocal microscopy, coverslips with transfected cells
were placed in a microscopy quality glass-bottom plate (WillCo) and ana-
lyzed with the same confocal system. Confocal FRET measurements were
done in vivo using the same technique, stimulating cells with the 458-nm
band of the Argon laser. To calculate FRETs, the ratio of emission intensi-
ties at 535–480 nm was calculated for each pixel using the LSM-510
Zeiss software. Bars represent 10  m in all micrographs.
Western blotting
Cells were seeded in 6-well plates and transfected the next day. At the
end of the experiment, cells were lysed in a buffer containing 1% Igepal
CA-630 detergent (Sigma-Aldrich), 150 mM NaCl, 50 mM Tris, pH 7.5,
5 mM EDTA, and protease inhibitors aprotinin (10  g/ml), leupeptin (10
 g/ml), and PMSF (1 mM; Roche). After a 5-min centrifugation, protein
concentrations were measured using the Bradford method (Bio-Rad Labo-
ratories). Equal amounts of protein were resolved by SDS-PAGE, trans-
ferred to a polyvinylidene difluoride membrane (Millipore), and probed
with specific antibodies against PARP (clone C2-10, mAb; Becton Dickin-
son), AU1 (mAb; Babco), Bak (rabbit polyclonal; Becton Dickinson), or
Bax (N-20, rabbit polyclonal; Santa Cruz Biotechnology, Inc.). After an
additional incubation with appropriate secondary HRP-coupled antibodies
(DakoCytomation), blots were developed by chemiluminescence using
the ECL system (Amersham Biosciences). When reprobed, membranes
were previously stripped for 15 min in a 7 M guanidinium hydrochloride
(Sigma-Aldrich) solution.
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